Cat. No.: DIA-0231305
Product Information | |
---|---|
CAS No. | 19885-10-0 |
Formula | C30H50O5 |
Molecular Weight | 490.715 |
SMILES | CC(CC(O)C(O)C(C)(C)O)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1 |
Product Description | Alisol A presents inhibitory effects on cancer cell lines tested(HepG2, MDA-MB-231, and MCF-7 cells). Alisol A enhances LC3II expression, indicates autophagy is occured, suggests that alisol A may be an autophagic inducer. |
Format & Storage | |
---|---|
Format | Solid |
Purity | > 98% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.